COVID-19, Systemic Lupus Erythematosus
Conditions
Brief summary
Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).
Detailed description
Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).
Interventions
BEHAVIORALLEAP Education + Navigation
COVID education involving providing information about COVID for people with SLE and CDC recommendations for testing, testing options (e.g., pharmacies, doctors' offices, at-home), treatment in the event of a positive COVID result, and current recommendations around vaccination for those with SLE; and (2) navigation, which involves individual tailoring of information about where and how to get tested, and where to get vaccinated, and when appropriate, guiding participants in scheduling testing and vaccination appointments.
BEHAVIORALLEAP Education
COVID education involving providing information about COVID for people with SLE and CDC recommendations for testing, testing options (e.g., pharmacies, doctors' offices, at-home), treatment in the event of a positive COVID result, and current recommendations around vaccination for those with SLE.
Sponsors
University of Alabama at Birmingham
Ochsner Health System
Louisiana State University Health Sciences Center in New Orleans
Tulane University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)
Intervention model description
This is a two-arm study in which participants are randomized to an experimental (education + navigation) or comparison (education only) group.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
18 years or older, ability to understand and speak English, diagnosis of SLE
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of COVID testing | 3 months | Participant-reported COVID testing |
| Incidence of COVID-19 Vaccination | 3 months | Participant-reported COVID vaccination |
Countries
United States
Outcome results
None listed